Search research articles
Contact Us
Filters
Showing results (1-10 of 172) with videos related to
Page
of 18
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
February 18, 2010
[PPARgamma and cancer]
Hitoshi Nakagama
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
May 20, 2015
[A roadmap toward total elimination of cancer]
Koji Okamoto, Hitoshi Nakagama
Mutation Research
|
October 2, 2010
MicroRNA, SND1, and alterations in translational regulation in colon carcinogenesis
Naoto Tsuchiya, Hitoshi Nakagama
Medicinal Research Reviews
|
May 23, 2013
FGF receptors: cancer biology and therapeutics
Masaru Katoh, Hitoshi Nakagama
Plos One
|
March 13, 2008
The anti-proliferative effects of the CHFR depend on the forkhead associated domain, but not E3 ligase activity mediated by ring finger domain
Tomokazu Fukuda, Yasuyuki Kondo, Hitoshi Nakagama
Cancer Science
|
October 20, 2005
Modeling human colon cancer in rodents using a food-borne carcinogen, PhIP
Hitoshi Nakagama, Masako Nakanishi, Masako Ochiai
FEBS Letters
|
July 22, 2009
Mdmx enhances p53 ubiquitination by altering the substrate preference of the Mdm2 ubiquitin ligase
Koji Okamoto, Yoichi Taya, Hitoshi Nakagama
Genes, Chromosomes & Cancer
|
October 21, 2003
Poly(ADP-ribose) and carcinogenesis
Mitsuko Masutani, Hitoshi Nakagama, Takashi Sugimura
Proceedings of the National Academy of Sciences of the United States of America
|
September 19, 2007
Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells
Hiroshi Tazawa, Naoto Tsuchiya, Masashi Izumiya, et al.
Japanese Journal of Clinical Oncology
|
August 8, 2020
Present status of support for adolescent and young adult cancer patients in member hospitals of Japanese Association of Clinical Cancer Centers
Hideki Nakayama, Yasushi Toh, Manami Fujishita, et al.
Page
of 18
Search research articles
Search
Showing results (1-10 of 172) with videos related to
Sort By:
Page
of 18
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
February 18, 2010
[PPARgamma and cancer]
Hitoshi Nakagama
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
May 20, 2015
[A roadmap toward total elimination of cancer]
Koji Okamoto, Hitoshi Nakagama
Mutation Research
|
October 2, 2010
MicroRNA, SND1, and alterations in translational regulation in colon carcinogenesis
Naoto Tsuchiya, Hitoshi Nakagama
Medicinal Research Reviews
|
May 23, 2013
FGF receptors: cancer biology and therapeutics
Masaru Katoh, Hitoshi Nakagama
Plos One
|
March 13, 2008
The anti-proliferative effects of the CHFR depend on the forkhead associated domain, but not E3 ligase activity mediated by ring finger domain
Tomokazu Fukuda, Yasuyuki Kondo, Hitoshi Nakagama
Cancer Science
|
October 20, 2005
Modeling human colon cancer in rodents using a food-borne carcinogen, PhIP
Hitoshi Nakagama, Masako Nakanishi, Masako Ochiai
FEBS Letters
|
July 22, 2009
Mdmx enhances p53 ubiquitination by altering the substrate preference of the Mdm2 ubiquitin ligase
Koji Okamoto, Yoichi Taya, Hitoshi Nakagama
Genes, Chromosomes & Cancer
|
October 21, 2003
Poly(ADP-ribose) and carcinogenesis
Mitsuko Masutani, Hitoshi Nakagama, Takashi Sugimura
Proceedings of the National Academy of Sciences of the United States of America
|
September 19, 2007
Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells
Hiroshi Tazawa, Naoto Tsuchiya, Masashi Izumiya, et al.
Japanese Journal of Clinical Oncology
|
August 8, 2020
Present status of support for adolescent and young adult cancer patients in member hospitals of Japanese Association of Clinical Cancer Centers
Hideki Nakayama, Yasushi Toh, Manami Fujishita, et al.
Page
of 18